tiprankstipranks
Trending News
More News >
Karolinska Development AB Class B (SE:KDEV)
:KDEV

Karolinska Development AB (KDEV) Price & Analysis

Compare
0 Followers

KDEV Stock Chart & Stats


---

KDEV FAQ

What was Karolinska Development AB Class B’s price range in the past 12 months?
Currently, no data Available
What is Karolinska Development AB Class B’s market cap?
Currently, no data Available
When is Karolinska Development AB Class B’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Karolinska Development AB Class B’s earnings last quarter?
Currently, no data Available
Is Karolinska Development AB Class B overvalued?
According to Wall Street analysts Karolinska Development AB Class B’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Karolinska Development AB Class B pay dividends?
    Karolinska Development AB Class B does not currently pay dividends.
    What is Karolinska Development AB Class B’s EPS estimate?
    Karolinska Development AB Class B’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Karolinska Development AB Class B have?
    Currently, no data Available
    What happened to Karolinska Development AB Class B’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Karolinska Development AB Class B?
    Currently, no hedge funds are holding shares in SE:KDEV
    ---

    Company Description

    Karolinska Development AB Class B

    Karolinska Development AB engages in the investment in pharmaceutical business. It focuses on identifying medical innovations and investing in the creation and growth of companies that develop these assets into differentiated products that will make a difference to patient's lives. The company was founded in 2006 and is headquartered in Solna, Sweden.
    ---
    Popular Stocks
    ---
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis